V
Vittoria Biotherapeutics
Focuses on expanding the applications for CAR-based therapeutics using Novel Cell Engineering Technologies
About Vittoria Biotherapeutics
Vittoria Bio is a clinical-stage biotechnology company specializing in next-generation cell therapy and gene editing technologies. The company focuses on developing innovative treatments for oncology and autoimmune diseases, leveraging advanced gene editing techniques to enhance the efficacy and safety of cell therapies. Vittoria Bio serves the healthcare sector, particularly targeting unmet clinical needs in cancer and autoimmune disorders. The business model involves generating proof-of-concept clinical data for its lead programs, such as Viper 101, in a cost-effective manner to achieve rapid market penetration. Revenue is primarily derived from strategic partnerships, licensing agreements, and potential future sales of its proprietary therapies. The company operates in the highly competitive biotechnology market, collaborating with industry leaders like Metagenomi to stay at the forefront of technological advancements.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Nov 2024 | $0 | — | Agent Capital · Tellus BioVentures · Global BioAccess Fund · University of Pennsylvania | ↗ |
| EARLY VC✓Equity / VC | Nov 2023 | $15M | $60M | The Leukemia & Lymphoma Society · Tellus BioVentures · BioAdvance · Agent Capital | ↗ |
Growth signals
Latest recorded traffic for Vittoria Biotherapeutics is 2.8K monthly website visits, up 100% over the last three months. Vittoria Biotherapeutics's team grew 8.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Vittoria Biotherapeutics in the Philadelphia ecosystem
The Vittoria Biotherapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Agent Capital
Tellus BioVentures
SV Health Investors
Series A7 investors entered at this stage
- VIValley Forge Investment
The Leukemia & Lymphoma Society
BioAdvance
University of Pennsylvania
NYBC Ventures
Global BioAccess Fund
Hatch Biofund Management
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Vittoria Biotherapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Vittoria Biotherapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










